Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Mindray Medical International Ltd Company Profile (NYSE:MR)

Consensus Ratings for Mindray Medical International Ltd (NYSE:MR) (?)
Ratings Breakdown: 3 Sell Rating(s), 4 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 1.89)
Consensus Price Target: $30.50 (1.45% downside)

Current Analysts' Coverage Summary for Mindray Medical International Ltd (NYSE:MR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/30/2015ZacksUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/11/2015JMP SecuritiesLower Price TargetMarket Underperform$23.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2015Credit Suisse Group AGDowngradeNeutral -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
3/6/2015Deutsche BankSet Price TargetBuy$34.00ViewTweet This Rating  Share This Rating on StockTwits
1/20/2015TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
12/22/2014Standpoint ResearchInitiated CoverageBuy$36.00ViewTweet This Rating  Share This Rating on StockTwits
12/12/2014Morgan StanleyDowngradeEqual Weight -> Underweight$37.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Jefferies GroupLower Price TargetHold$36.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/7/2014Goldman SachsDowngradeBuy -> Neutral$45.50 -> $31.20ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014OppenheimerLower Price TargetOutperform$50.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2013Piper JaffrayDowngradeOverweight -> Neutral$40.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/26/2013 forward)